Irak4 inhibitor for the treatment of respiratory diseases

Abstract

The present application relates to chemical compound of Formula (I), that inhibit IRAK4 and consequently have potential utility in medicine. that inhibit IRAK4 and consequently have potential utility in medicine for example in treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), of cancer, of inflammatory diseases, and of autoinflammatory / autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, myositis, Sjögren's syndrome, systemic sclerosis, gout, endometriosis, atopic dermatitis and psoriasis.